Lenalid Capsule (Lenalidomide) – Multiple Myeloma & Lepra Reaction Treatment
Lenalid (Lenalidomide) (generic equivalent to Revlimid) is a prescription targeted oncology medication for the treatment of multiple myeloma and lepra reaction (erythema nodosum leprosum). As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Lenalidomide (5mg / 10mg / 15mg / 25mg)
Manufacturer: Natco Pharma Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.
Composition Lenalidomide
Dosage Form Capsules
Equivalent brand Revlimid
Generic Name Lenalidomide
Indication Multiple myeloma, Lepra reaction
Manufacturer Natco Pharma Ltd
Packaging 30 capsules in 1 bottle
RxMed Kart's sole intention is to ensure that its consumers get expert-reviewed, accurate, and trustworthy information. However, the information contained herein should NOT use as a substitute for a qualified physician's advice. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.